179 related articles for article (PubMed ID: 37863888)
1. Adipose-enriched peri-tumoral stroma, in contrast to myofibroblast-enriched stroma, prognosticates poorer survival in breast cancers.
Lau HSH; Tan VKM; Tan BKT; Sim Y; Quist J; Thike AA; Tan PH; Pervaiz S; Grigoriadis A; Sabapathy K
NPJ Breast Cancer; 2023 Oct; 9(1):84. PubMed ID: 37863888
[TBL] [Abstract][Full Text] [Related]
2. Value of the Tumor-Stroma Ratio and Structural Heterogeneity Measured by a Novel Semiautomatic Image Analysis Technique for Predicting Survival in Patients With Colon Cancer.
Inoue H; Kudou M; Shiozaki A; Kosuga T; Shimizu H; Kiuchi J; Arita T; Konishi H; Komatsu S; Kuriu Y; Morinaga Y; Konishi E; Otsuji E
Dis Colon Rectum; 2023 Nov; 66(11):1449-1461. PubMed ID: 36649165
[TBL] [Abstract][Full Text] [Related]
3. Combined analysis of receptor expression reflects inter-and intra-tumor heterogeneity in HR+/HER2+ breast cancer.
Ju J; Du F; Gao SL; Si YR; Hu NL; Liu DX; Wang X; Yue J; Zheng FC; Kang YK; Yang ZX; Ma F; Xu BH; Yuan P
Breast Cancer Res Treat; 2022 Jul; 194(2):221-230. PubMed ID: 35699854
[TBL] [Abstract][Full Text] [Related]
4. Expression of matrix metalloproteinases and their inhibitors in different immunohistochemical-based molecular subtypes of breast cancer.
Kim GE; Lee JS; Choi YD; Lee KH; Lee JH; Nam JH; Choi C; Kim SS; Park MH; Yoon JH; Kweon SS
BMC Cancer; 2014 Dec; 14():959. PubMed ID: 25510449
[TBL] [Abstract][Full Text] [Related]
5. Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profiling.
Karthik GM; Rantalainen M; Stålhammar G; Lövrot J; Ullah I; Alkodsi A; Ma R; Wedlund L; Lindberg J; Frisell J; Bergh J; Hartman J
BMC Cancer; 2017 Nov; 17(1):802. PubMed ID: 29187174
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric evaluation of preoperative MRI in early stage breast cancer: prognostic impact of peri-tumoral fat.
Obeid JP; Stoyanova R; Kwon D; Patel M; Padgett K; Slingerland J; Takita C; Alperin N; Yepes M; Zeidan YH
Clin Transl Oncol; 2017 Feb; 19(2):211-218. PubMed ID: 27364695
[TBL] [Abstract][Full Text] [Related]
7. Identification of an immune-suppressed subtype of feline triple-negative basal-like invasive mammary carcinomas, spontaneous models of breast cancer.
Dagher E; Simbault L; Abadie J; Loussouarn D; Campone M; Nguyen F
Tumour Biol; 2020 Jan; 42(1):1010428319901052. PubMed ID: 31959092
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Tumor Microenvironment Heterogeneity among Breast Cancer Subtypes to Identify Subtype-Specific Signatures.
Li J; Wu J; Han J
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672784
[TBL] [Abstract][Full Text] [Related]
9. Differences in intra-tumoral macrophage infiltration and radiotherapy response among intrinsic subtypes in pT1-T2 breast cancers treated with breast-conserving surgery.
Garvin S; Vikhe Patil E; Arnesson LG; Oda H; Hedayati E; Lindström A; Shabo I
Virchows Arch; 2019 Aug; 475(2):151-162. PubMed ID: 30915533
[TBL] [Abstract][Full Text] [Related]
10. The Significance of the Stromal Response in Breast Cancer: An Immunohistochemical Study of Myofibroblasts in Primary and Metastatic Breast Cancer.
Roozdar A; Hayes MM; Pourseyedei B; Zeinalinejad H; Shamsi Meymandi M; Dabiri B; Dabiri S
Arch Iran Med; 2018 May; 21(5):185-190. PubMed ID: 29738261
[TBL] [Abstract][Full Text] [Related]
11. Identification of key tumor stroma-associated transcriptional signatures correlated with survival prognosis and tumor progression in breast cancer.
Uddin MN; Wang X
Breast Cancer; 2022 May; 29(3):541-561. PubMed ID: 35020130
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression of chemokine C-C ligand 2 in stroma is associated with recurrent basal-like breast cancers.
Yao M; Yu E; Staggs V; Fan F; Cheng N
Mod Pathol; 2016 Aug; 29(8):810-23. PubMed ID: 27125354
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of intra-tumoral estradiol level in breast cancer patients.
Miyoshi Y; Akazawa K; Kamigaki S; Ueda S; Yanagisawa T; Inoue T; Yamamura J; Taguchi T; Tamaki Y; Noguchi S
Cancer Lett; 2004 Dec; 216(1):115-21. PubMed ID: 15500955
[TBL] [Abstract][Full Text] [Related]
14. Lymphocytic infiltrate is associated with favorable biomarkers profile in HER2-overexpressing breast cancers and adverse biomarker profile in ER-positive breast cancers.
Tsang JY; Hui SW; Ni YB; Chan SK; Yamaguchi R; Kwong A; Law BK; Tse GM
Breast Cancer Res Treat; 2014 Jan; 143(1):1-9. PubMed ID: 24272079
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive profiling of the immune microenvironment of breast cancer brain metastases.
Griguolo G; Tosi A; Dieci MV; Fineberg S; Rossi V; Ventura A; Bottosso M; Bauchet L; Miglietta F; Jacob J; Rigau V; Fassan M; Jacot W; Conte P; Rosato A; Darlix A; Guarneri V
Neuro Oncol; 2022 Dec; 24(12):2146-2158. PubMed ID: 35609559
[TBL] [Abstract][Full Text] [Related]
16. Gene expression signatures of morphologically normal breast tissue identify basal-like tumors.
Finak G; Sadekova S; Pepin F; Hallett M; Meterissian S; Halwani F; Khetani K; Souleimanova M; Zabolotny B; Omeroglu A; Park M
Breast Cancer Res; 2006; 8(5):R58. PubMed ID: 17054791
[TBL] [Abstract][Full Text] [Related]
17. Arousal of cancer-associated stroma: overexpression of palladin activates fibroblasts to promote tumor invasion.
Brentnall TA; Lai LA; Coleman J; Bronner MP; Pan S; Chen R
PLoS One; 2012; 7(1):e30219. PubMed ID: 22291919
[TBL] [Abstract][Full Text] [Related]
18. High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.
Olbrecht S; Busschaert P; Qian J; Vanderstichele A; Loverix L; Van Gorp T; Van Nieuwenhuysen E; Han S; Van den Broeck A; Coosemans A; Van Rompuy AS; Lambrechts D; Vergote I
Genome Med; 2021 Jul; 13(1):111. PubMed ID: 34238352
[TBL] [Abstract][Full Text] [Related]
19. Combining radiomics and deep learning features of intra-tumoral and peri-tumoral regions for the classification of breast cancer lung metastasis and primary lung cancer with low-dose CT.
Li L; Zhou X; Cui W; Li Y; Liu T; Yuan G; Peng Y; Zheng J
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15469-15478. PubMed ID: 37642722
[TBL] [Abstract][Full Text] [Related]
20. A genomic ruler to assess oncogenic transition between breast tumor and stroma.
Dhage S; Ernlund A; Ruggles K; Axelrod D; Berman R; Roses D; Schneider RJ
PLoS One; 2018; 13(10):e0205602. PubMed ID: 30325954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]